Transapical transcatheter aortic valve replacement using Ken-Valve for severe aortic stenosis combined with severe aortic regurgitation: A case report_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

LIU Lulu , KANG Zhefeng , SHI Jun ,  GUO Yingqiang

Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China;

Corresponding author：

GUO Yingqiang, Email: drguoyq@hotmail.com

Keywords：

Aortic regurgitation; aortic stenosis; transcatheter aortic valve replacement; Ken-Valve prosthesis

DOI：

10.7507/1007-4848.202107095

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Transcatheter aortic valve replacement (TAVR) for severe aortic stenosis is growing rapidly. The use of new heart valves prosthesis has improved surgical safety and efficacy. This report described a 72-year-old male patient with severe aortic stenosis combined with severe aortic regurgitation, who was evaluated at moderate-high risk of surgery and received a transapical TAVR using the Ken-Valve heart valve. The transcatheter operation time was 8 min, and the blood loss was 50 mL. The tracheal intubation was removed immediately after the surgery. Transesophageal echocardiography on the 4th postoperative day showed that the aortic valve leaflets worked well, and there was no valve orifice and paravalvular leakage. The patient was discharged on the 5th day after the surgery without complications. Transapical TAVR using Ken-Valve was an easy surgical procedure for aortic valve disease, and had short operation time.

Citation： LIU Lulu, KANG Zhefeng, SHI Jun, GUO Yingqiang. Transapical transcatheter aortic valve replacement using Ken-Valve for severe aortic stenosis combined with severe aortic regurgitation: A case report. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2022, 29(5): 658-661. doi: 10.7507/1007-4848.202107095 Copy

1.	Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation, 2002, 106(24): 3006-3008.
2.	Baralis G, Musumeci G, Musumeci F. Lo studio SURTAVI [The SURTAVI study]. G Ital Cardiol (Rome). 2017, 18(12): 814-819.
3.	Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med, 2011, 364(23): 2187-2198.
4.	Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med, 2014, 370(19): 1790-1798.
5.	Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 2017, 135(25): e1159-e1195.
6.	Writing Committee Members, Otto CM, Nishimura RA, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol, 2021, 77(4): 450-500.
7.	Wernly B, Eder S, Navarese EP, et al. Transcatheter aortic valve replacement for pure aortic valve regurgitation: "On-label" versus "off-label" use of TAVR devices. Clin Res Cardiol, 2019, 108(8): 921-930.
8.	刘庆荣, 吕守良, 吴永健. 国产Venus A-Valve人工主动脉瓣膜的设计特点. 中国医刊, 2015, 1: 9-10.
9.	Hwang EH, Ju JK, Cho MJ, et al. Giant coronary aneurysm caused by Kawasaki disease: Consistency between catheter angiography and electrocardiogram gated dual-source computed tomography angiography. Korean J Pediatr, 2015, 58(12): 501-504.
10.	Zhou D, Pan W, Wang J, et al. VitaFlow™ transcatheter valve system in the treatment of severe aortic stenosis: One-year results of a multicenter study. Catheter Cardiovasc Interv, 2020, 95(2): 332-338.
11.	Wang Y, Jiang W, Liu J, et al. Early surgery versus conventional treatment for asymptomatic severe aortic regurgitation with normal ejection fraction and left ventricular dilatation. Eur J Cardiothorac Surg, 2017, 52(1): 118-124.
12.	Liu L, Chen S, Shi J, et al. Transcatheter aortic valve replacement in aortic regurgitation. Ann Thorac Surg, 2020, 110(6): 1959-1965.
13.	Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The valve academic research consortium-2 consensus document. Eur Heart J, 2012, 33(19): 2403-2418.
14.	Arora S, Vavalle JP. Transcatheter aortic valve replacement in intermediate and low risk patients-clinical evidence. Ann Cardiothorac Surg, 2017, 6(5): 493-497.
15.	VARC-3 Writing Committee, Généreux P, Piazza N, et al. Valve academic research consortium 3: Updated endpoint definitions for aortic valve clinical research. Eur Heart J, 2021, 42(19): 1825-1857.
16.	Ueshima D, Nai Fovino L, Brener SJ, et al. Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis. Int J Cardiol, 2020, 298: 76-82.

1. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation, 2002, 106(24): 3006-3008.
2. Baralis G, Musumeci G, Musumeci F. Lo studio SURTAVI [The SURTAVI study]. G Ital Cardiol (Rome). 2017, 18(12): 814-819.
3. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med, 2011, 364(23): 2187-2198.
4. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med, 2014, 370(19): 1790-1798.
5. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 2017, 135(25): e1159-e1195.
6. Writing Committee Members, Otto CM, Nishimura RA, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol, 2021, 77(4): 450-500.
7. Wernly B, Eder S, Navarese EP, et al. Transcatheter aortic valve replacement for pure aortic valve regurgitation: "On-label" versus "off-label" use of TAVR devices. Clin Res Cardiol, 2019, 108(8): 921-930.
8. 刘庆荣, 吕守良, 吴永健. 国产Venus A-Valve人工主动脉瓣膜的设计特点. 中国医刊, 2015, 1: 9-10.
9. Hwang EH, Ju JK, Cho MJ, et al. Giant coronary aneurysm caused by Kawasaki disease: Consistency between catheter angiography and electrocardiogram gated dual-source computed tomography angiography. Korean J Pediatr, 2015, 58(12): 501-504.
10. Zhou D, Pan W, Wang J, et al. VitaFlow™ transcatheter valve system in the treatment of severe aortic stenosis: One-year results of a multicenter study. Catheter Cardiovasc Interv, 2020, 95(2): 332-338.
11. Wang Y, Jiang W, Liu J, et al. Early surgery versus conventional treatment for asymptomatic severe aortic regurgitation with normal ejection fraction and left ventricular dilatation. Eur J Cardiothorac Surg, 2017, 52(1): 118-124.
12. Liu L, Chen S, Shi J, et al. Transcatheter aortic valve replacement in aortic regurgitation. Ann Thorac Surg, 2020, 110(6): 1959-1965.
13. Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The valve academic research consortium-2 consensus document. Eur Heart J, 2012, 33(19): 2403-2418.
14. Arora S, Vavalle JP. Transcatheter aortic valve replacement in intermediate and low risk patients-clinical evidence. Ann Cardiothorac Surg, 2017, 6(5): 493-497.
15. VARC-3 Writing Committee, Généreux P, Piazza N, et al. Valve academic research consortium 3: Updated endpoint definitions for aortic valve clinical research. Eur Heart J, 2021, 42(19): 1825-1857.
16. Ueshima D, Nai Fovino L, Brener SJ, et al. Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis. Int J Cardiol, 2020, 298: 76-82.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Transapical transcatheter aortic valve replacement using Ken-Valve for severe aortic stenosis combined with severe aortic regurgitation: A case report

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content